Neos Therapeutics Other Current Liabilities

Neos Therapeutics (NEOS) currently reports a other current liabilities of $32M as of September 2020. That compares with $38M in the prior-year period — down 17.0% year over year. Use the charts on this page to explore Neos Therapeutics's other current liabilities history and peer comparisons.

Neos Therapeutics's other current liabilities decreased from $38M to $32M — a 17.0% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neos Therapeutics reported $32M in other current liabilities as of September 2020. That compares with $38M in the prior-year period — down 17.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $32M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neos Therapeutics, and consider following NEOS for alerts when major investors trade the stock.

Neos Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $32M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NEOS with unrelated industries.